StateReg.Reference
Cannabis laws
Hawaii

Hawaii Cannabis Laws: Medical, Decriminalization, and Future Outlook

Hawaii cannabis laws: medical marijuana program, decriminalization of small amounts, and federal conflicts. Learn about recent legislative efforts and the future outlook for cannabis in the Aloha State.

By Steven Cooper · Founder & Editor
Verified June 7, 20267 statute sources
AI-drafted, human-reviewed

How we build these guides

Sourcing

Adapters pull primary data from the FAA, IRS, OpenStates, DSIRE, NORML, PubMed, Census/BLS/FRED, Google Civic, and Data.gov.

Generation pipeline

Multi-stage AI pipeline: structural outline → long-form draft → cross-family fact-check editor → readability polish → FAQ enrichment. Each stage uses a different model family so factual drift is caught before publish.

Quality gates

Soft gates on word count, citation count, and banned-phrase screening; hard blocks if required sections are missing.

Verification cadence

Pages are re-verified quarterly. verified_at updates on every pass.

Not legal advice. Consult an attorney or CPA for binding guidance.

HawaiiCannabis laws
#38 of 50·3 state statutes cited·Light state coverage

Quick Answer: Hawaii Cannabis Laws at a Glance

  • Medical cannabis: Legal for registered patients under Hawaii Revised Statutes (HRS) Chapter 329D.
  • Recreational cannabis: Illegal. No adult-use program exists.
  • Small possession: Decriminalized. Possession of up to 3 grams is a civil infraction, not a criminal offense, under Hawaii House Bill 1383 (2019).
  • Federal law: Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act (21 U.S.C. § 812). This classification overrides state law in federal jurisdictions and creates significant challenges for businesses and patients.

Hawaii's Medical Cannabis Program: Patient and Caregiver Guidelines

Hawaii legalized medical cannabis in 2000. The program is governed by HRS Chapter 329D and administered by the Hawaii Department of Health (DOH) Medical Cannabis Registry Program.

Patient Registration

To participate, a patient must obtain a written certification from a licensed Hawaii physician or advanced practice registered nurse. This provider must have a bona fide patient-provider relationship and determine the patient has a qualifying condition. After certification, the patient registers with the DOH Medical Cannabis Registry Program and receives a registry identification card. Consult the Hawaii DOH Medical Cannabis Registry Program for current application fees and processing timelines.

Qualifying Medical Conditions

The DOH maintains the official list of qualifying conditions under HRS Chapter 329D. The DOH can add conditions through a petition process. Consult the Hawaii DOH Medical Cannabis Registry Program for the current, complete list of qualifying conditions, as it is subject to amendment.

Possession Limits

Registered patients and their designated caregivers may possess a defined quantity of usable cannabis under HRS Chapter 329D. Consult the Hawaii DOH Medical Cannabis Registry Program for current possession limits.

Designated Caregivers

A registered patient unable to cultivate or obtain cannabis independently may designate a caregiver. The caregiver must also register with the DOH Medical Cannabis Registry Program. Consult the Hawaii DOH Medical Cannabis Registry Program for caregiver registration requirements, including background check specifics and patient limits. Caregivers may possess cannabis on behalf of their registered patients within the same limits that apply to patients under HRS Chapter 329D.

The Licensed Dispensary System

Hawaii operates a licensed dispensary system under HRS Chapter 329D. Dispensaries are the only legal retail point of sale for medical cannabis in the state. The DOH licenses them and oversees ongoing compliance requirements for cultivation, processing, testing, and retail operations. The number of dispensary licenses issued is capped by statute. For current licensee locations and license counts, consult the Hawaii DOH Medical Cannabis Registry Program dispensary directory.

Inter-Island Transport: HB 290 Veto

In 2019, the legislature passed House Bill 290, which would have allowed registered patients to transport medical cannabis between islands. Governor Ige vetoed the bill. He stated that cannabis remains illegal under federal law, and both the airspace and certain navigable waters between Hawaii's islands fall under exclusive federal jurisdiction (NORML state law summary, citing Governor Ige's veto message on HB 290). Patients relying on state authorization to carry cannabis through federal jurisdictions could face federal prosecution.

This veto exemplifies how federal prohibition creates gaps in state programs. Until federal law changes, registered patients cannot legally transport medical cannabis between islands through federally regulated corridors. Inter-island patients must obtain cannabis from a dispensary on each island they visit.


Decriminalization in Hawaii: Understanding the 2019 Law

What Decriminalization Means

Decriminalization removes criminal penalties, such as jail time and a criminal record, for specific conduct. It replaces them with a civil penalty, usually a fine. Individuals can still be cited and fined but will not be arrested or prosecuted criminally for the covered quantity.

What HB 1383 (2019) Did

Governor Ige allowed Hawaii House Bill 1383 (2019) to become law without his signature. The law amended HRS Chapter 712 (Offenses Against Public Health and Morals) to eliminate criminal penalties for possession of up to 3 grams of cannabis. Possession of that quantity is now a civil infraction.

QuantityLegal StatusPenalty Type
Up to 3 gramsCivil infractionFine (consult Hawaii State Judiciary or relevant county court for current amount)
Over 3 grams (non-registered)Criminal offenseConsult HRS Chapter 712 for applicable charges
Registered patient, within limitsLegal under HRS Chapter 329DNo penalty

Expungement of Prior Convictions

HB 1383 (2019) included an expungement provision. Individuals previously convicted of a cannabis possession offense involving no more than 3 grams may petition the courts for an expungement order under the procedures established by the bill (Hawaii House Bill 1383, 2019). This process is not automatic; the individual must initiate it. Consult a Hawaii criminal defense attorney or the Hawaii State Judiciary for the applicable petition process.

Practical Limits of Decriminalization

Decriminalization applies only to state law. Federal law still classifies any cannabis possession as a criminal offense under 21 U.S.C. § 812. State decriminalization provides no protection on federal property, in federal buildings, airports, or any federally regulated space. Employers with federal contracts may also maintain drug-free workplace policies that treat cannabis as any other controlled substance, regardless of state law.


Federal Conflict: IRC §280E and Cannabis Business Challenges in Hawaii

The Root Problem: Schedule I Classification

Cannabis is classified as a Schedule I controlled substance under the federal Controlled Substances Act (21 U.S.C. § 812). Schedule I indicates the federal government considers it to have no accepted medical use and a high potential for abuse. This classification persists despite state-level legalization across dozens of states. Every conflict between state cannabis law and federal law—from banking access to tax treatment to inter-island transport—traces back to this federal classification.

How IRC §280E Works

Internal Revenue Code §280E is the tax provision most impactful for cannabis businesses. It disallows ordinary and necessary business expense deductions for any trade or business trafficking in Schedule I or II controlled substances. Because cannabis is Schedule I under federal law, the IRS treats every state-licensed dispensary in Hawaii as a drug trafficking operation for federal tax purposes, regardless of its compliance with HRS Chapter 329D.

This means a Hawaii dispensary cannot deduct rent, employee wages, utilities, marketing costs, or most other standard operating expenses that other retail businesses deduct. IRC §280E blocks these deductions.

The COGS Exception

The one deduction that survives IRC §280E is Cost of Goods Sold (COGS). A cannabis business can still deduct the direct costs of producing or acquiring the product it sells. For a vertically integrated dispensary that cultivates, processes, and retails cannabis, careful COGS accounting is critical. It is the primary tool for reducing taxable income under the current federal framework.

Inventory accounting and cost allocation are thus far more consequential for cannabis businesses than for ordinary retailers. The distinction between what qualifies as COGS versus an operating expense significantly affects effective tax rates.

The Effective Tax Burden

Because ordinary business expenses are not deductible, cannabis businesses often pay federal income tax on gross profit rather than net profit. Effective federal tax rates for cannabis businesses can reach 70 percent or higher, depending on the business's cost structure. This is not a penalty; it results from normal tax rates applied to an inflated taxable income figure due to unavailable deductions.

The Stackable Nature of §280E

IRC §280E applies regardless of state law. A Hawaii dispensary operating in full compliance with HRS Chapter 329D, licensed by the DOH, and serving only registered patients still faces the full §280E burden. State legality does not provide federal tax relief. This burden is "stackable": it adds to state and local tax obligations, with state compliance offering no offset.

The only path to §280E relief for cannabis businesses is federal rescheduling or descheduling of cannabis. The DEA has had rulemaking proceedings on cannabis scheduling underway, but cannabis remains Schedule I as of this writing. Consult the DEA's official rulemaking docket and a qualified cannabis tax attorney for current status.

Banking and Beyond

Federal illegality also impacts banking access. Most federally insured banks and credit unions decline to serve cannabis businesses, citing regulatory risk. Hawaii dispensaries often operate largely in cash, creating security costs and accounting complications that further compress margins already squeezed by §280E. Hawaii's geographic isolation exacerbates cash logistics challenges.


Future Outlook

Hawaii's legislature has considered adult-use legalization bills in multiple recent sessions, but none have passed as of this writing. The state's political environment has historically favored a cautious approach. Governor Ige made this posture explicit when he stated that Hawaii "can benefit from not being at the head of the table" on cannabis liberalization (NORML state law summary). Whether this posture changes under future administrations or legislative sessions depends on uncertain factors.

For patients, caregivers, dispensary operators, and individuals with prior cannabis convictions in Hawaii, monitoring the Hawaii DOH Medical Cannabis Registry Program, the Hawaii State Legislature's bill tracking system, and the DEA's federal rescheduling proceedings is crucial. The legal landscape is dynamic, and the gaps between state permission and federal prohibition remain consequential until Congress or the DEA acts.


TL;DR: Hawaii allows medical cannabis for registered patients and decriminalized possession of small amounts (under 3 grams) in 2019. Recreational use is illegal. Federal law still classifies cannabis as illegal, causing tax problems for businesses and preventing inter-island transport for patients. Expungement for past minor possession offenses is possible.

Sources & Verification (7)
  • Controlled Substances Act 21 U.S.C. §812 — federal Schedule I status (HHS recommendation to Schedule III pending DEA finalization).
  • FinCEN Guidance FIN-2014-G001 — Marijuana-Related Businesses banking and SAR filing requirements.
  • IRC §280E — federal disallowance of business expense deductions for trafficking Schedule I/II substances.
  • Cole Memorandum (rescinded 2018) — historical federal enforcement guidance, replaced by case-by-case U.S. Attorney discretion.
  • RELATING TO HEMP.
  • RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
  • RELATING TO MEDICAL CANNABIS.

Last verified: June 7, 2026

Editorial process: See methodology →

How we verify: 9 source adapters (FAA, DSIRE, IRS, OpenStates, etc.) → AI draft → AI editor → AI polish → spot human review.

Affiliate disclosure: some links below are affiliate links (Amazon and partner programs). If you buy through them, we may earn a small commission at no extra cost to you. Product selection is not influenced by commission — see our full disclosure.